Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07210437 · ClinicalTrials.gov registry record · NA

Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI

A NA study of Spinal Cord Injuries, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT07210437 is a NA study of Spinal Cord Injuries that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 18 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07210437, a NA study of Spinal Cord Injuries, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to learn about how the body is able to balance changes in blood pressure, how that changes over time, and how these changes impact a participant's risk of developing medical problems.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Tests of sympathetic inhibition
  • DIAGNOSTIC_TEST Tests of above level sympathetic activation
  • DIAGNOSTIC_TEST Testing of below level sympathetic activation

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2026-01-31
Est. Completion 2028-06-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT07210437

The ClinicalTrials.gov registry entry for NCT07210437 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (71% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 3 interventions - of which Tests of sympathetic inhibition is the first listed.

NCT07210437 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07210437 about?

NCT07210437 is a clinical study titled "Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI". The purpose of this research is to learn about how the body is able to balance changes in blood pressure, how that changes over time, and how these changes impact a participant's risk of developing medical problems.

What is the current status of trial NCT07210437?

This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2026-01-31. Estimated completion is 2028-06-01.

What conditions does trial NCT07210437 study?

This clinical trial studies the following conditions: Spinal Cord Injuries.

What interventions are being tested in trial NCT07210437?

The interventions under investigation include: Tests of sympathetic inhibition (DIAGNOSTIC_TEST), Tests of above level sympathetic activation (DIAGNOSTIC_TEST), Testing of below level sympathetic activation (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07210437?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07210437 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.